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Abstract
Background: Community pharmacists play a crucial role in optimising medication use and improving patient
outcomes, whilst preventing medication misuse and reducing costs. Evidence suggests that pharmacists
counselling improves clinical outcomes, quality of life, drug and disease knowledge and reduces health service
utilisation. This study aims to investigate the counselling practices of community pharmacists in Riyadh, the capital
of Saudi Arabia.
Methods: The study consisted of two parts: simulated patients (SPs) visits to observe actual counselling practices,
and a cross-sectional survey of community pharmacists to assess their reported counselling practices. In the SPs
method, there were four scenarios involving four medications. Scenarios 1 and 2 concerned drug–drug interactions,
scenario 3 concerned the proper time of administration, and scenario 4 concerned side effects. The simulated visits
were conducted between April and May 2012. A four-sections questionnaire was distributed in the same period.
Results: We conducted 161 simulated visits. Out of the 161 visits a medicine was dispensed in 150 visits. When SPs
requested medications, pharmacists asked questions during 15 visits (10.0 %), provided information during 7 visits
(4.6 %), and both asked questions and provided information, i.e. provided counselling, during 4 visits (2.6 %). When
the SPs started to be inquisitive and demanded information, pharmacists asked SPs questions during 71 visits
(47.3 %), provided information during 150 visits (100 %), and both asked questions and provided information, i.e.
provided counselling, during 65 visits (43.3 %). Information regarding dose was the most common type of
information provided in 146 visits (97.3 %). After the SPs started to be inquisitive and probed for information, only
10 % were counselled on precautions. In the cross-sectional survey, four hundred pharmacists were approached
and 350 agreed to participate in the questionnaire (87 % response rate). Of the respondents, 223 (63.7 %) reported
that they usually or always tell the patient about the purpose of medicines or the diagnosis, 302 (86.2 %) reported
that they usually or always give patient information on how to use or apply the medicine; 299 (85.3 %) said they
were satisfied with their counselling practices.
Conclusions: The present study highlights the current deficiencies in appropriate dispensing practices and
medication counselling at community pharmacies in Saudi Arabia. Policy makers, stakeholders, and researchers
should collaborate to design interventions to improve the current dispensing practices at community pharmacies
across the country.
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Background
Community pharmacists play a crucial role in optimising
medication use and improving patient outcomes, whilst
preventing medication misuse and reducing costs [1, 2].
Patient counselling is an important service provided by
community pharmacies.
Patient education and counselling usually occur at
the time prescriptions are dispensed but may also be
provided as a separate service [3]. A systematic re-
view findings indicate that pharmacists led counselling
improves clinical outcomes, quality of life, drug and
disease knowledge, patients’ satisfaction with service,
and economic outcomes [4]. It is worth noting that
the counselling was more comprehensive and extended
beyond time of dispensing a medication in the majority of
the included trials in the review. At the time of dispensing,
evidence exist to suggest that community pharmacists’ in-
terventions such as counselling encourage appropriate
medicine use and prevents drug related problems [5, 6].
Many professional organizations have published guide-
lines that provide recommendations to pharmacists on
how to educate and counsel patients on both prescrip-
tion and non-prescription medicines [3, 7]. Although the
scope of content of the counselling recommended in
each guideline varies, all agree on providing the follow-
ing information: name and description of the medicine,
indications, route of administration, dose and dosage
form, directions for use, duration of therapy, special di-
rections, precautions, side effects, and contraindications
[3, 7]. All guidelines also emphasize that pharmacists
need to ask a series of questions to identify a patient’s
understanding of their medications, and to meet the spe-
cific needs of each patient and/or caregiver [3, 7].
There are approximately 7,322 community pharma-
cies in Saudi Arabia staffed by an estimated 12,506
pharmacists [8]. Community pharmacies are privately
owned and there are numerous chains of pharmacies.
Pharmacies are located in a variety of premises, with
the majority in main streets and some linked with pri-
vate healthcare clinics. According to the law regulating
Saudi pharmacy practice [9], all professional opera-
tions in a pharmacy must be performed by a licensed
pharmacist. Passing the Saudi Commission for Health
Specialties licensing exam is one requirement for the
licensing of pharmacists. The law prohibits medica-
tion dispensing without a prescription, unless the
medication is designated as over-the-counter (OTC).
The law also mandate that medications purchased
from a community pharmacy are dispensed in their
original packages with information package insert.
The outer package must include information such as
the name of the medication, active ingredients, pharma-
ceutical form, strength, storage condition, price, and
manufacturer.
A Saudi survey of 500 patients attending primary
healthcare centres indicated that 35.4 % of respondents
had practiced self-medication [10]. The authors defined
this as the use of drugs to treat self-diagnosed disorders
or symptoms, or the intermittent or continued use of a
prescribed drug for chronic or recurrent disease or
symptoms, in the preceding 2 weeks. The inappropriate
use of medicines by self-medicating consumers is re-
ported to be a factor contributing to medication errors
in the community, either alone or in combination with
other factors [11]. Community pharmacists play a key
role in counselling self-medicated patients. They moni-
tor the use of non-prescription medicines, identify
drug-related problems, and intervene when necessary
to ensure that patients use medicines safely, appropri-
ately, and effectively [2, 5]. In Saudi Arabia, it is com-
mon for prescription only medicines (POM) to be
supplied by community pharmacists without a doc-
tor’s prescription [12, 13]. This means that commu-
nity pharmacists are often the only point of contact
for patients before initiating drug therapy, not only
for OTC medication but also for POM.
This study aims to investigate the counselling practices
of community pharmacists in Riyadh, the capital of
Saudi Arabia when dispensing OTC and POM without a
prescription. Using simulated patients (SPs) visits and a
questionnaire, we assessed the following parameters:
counselling rate, types of questions asked, and informa-
tion provided during the counselling process.
Methods
The study consisted of two parts: simulated patients
visits and a cross-sectional survey of community phar-
macists. The simulated patients visits were used to as-
sess ‘real’ (unrehearsed) counselling practices, while the
survey was used to assess the community pharmacists’
reported counselling practices.
The simulated patient method
The simulated patient (SP) method was used to determine
how community pharmacists currently provide patient
counselling. This method has been employed extensively
in pharmacy practice-based research [12–18]. Within the
pharmacy context, a simulated patient is ‘an individual
who is trained to visit a pharmacy to enact a scenario that
tests a specific behaviour of the pharmacist or pharmacy
staff [19].
The simulated patients
The SPs were four female pharmacy students. Students
have been used as simulated clients in previous research
[12, 14, 16, 17]. We used four students, as a systematic
review of SP research in pharmacy practice recommends
using a minimum of two SPs [19]. The participation of
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the students was voluntary. The authors trained the SPs
using role-play to ensure the scenario was performed in
a consistent manner. Repeated rehearsal ensured reliabil-
ity of the simulated scenario. The actors used lay lan-
guage and refrained from using any jargon.
The pharmacies
The authors stratified Riyadh city using geographical
areas: north, south, west, east, and central. A convenient
sample of pharmacies in each area was selected. Each
pharmacy was visited once by one of the SPs. A pilot
study (N = 8 pharmacies) to test the content and delivery
of the scenarios was conducted. The results of the pilot
study were reviewed by the authors to ensure
consistency in the collection of data by the SPs. The SPs
visits for the current study were conducted between
April and May 2012.
The scenarios
There were four scenarios (Table 1). Two of the medica-
tions used in our scenarios are classified as POM in sce-
nario 2 (Amoxil) and scenario 4 (Zocor).
In scenario one, the patient is anaemic and asking for
iron (FeroseR). However, she is also frequently taking
antacid, which could prevent full iron absorption and
delay the response to iron therapy [20]. In scenario two,
the patient is asking for amoxicillin (AmoxilR), which is
a penicillin antibiotic known to alter intestinal flora that,
in turn, reduces the enterohepatic circulation of estrogen
metabolites. Concomitant use with birth control pills is
associated with unintended pregnancies and menstrual
changes. Therefore, pharmacists are expected to provide
SPs with a caution of unplanned pregnancy as a possible
result of the interaction between the antibiotic and
contraceptive pills [20]. In scenario three, a patient with
renal failure is asking for the antacid MoxalR (an
aluminium-containing antacid) as a phosphate-binding
agent. Pharmacists are expected to stress the need to
time the administration of phosphate-binding agents
with food intake to prevent phosphate absorption that
leads to hyperphosphatemia in patients with renal failure
[20]. In scenario four, SPs request simvastatin (ZocorR),
which is a lipid-lowering agent known to induce my-
opathy and rhabdomyolysis. Pharmacists are expected
to provide the SPs with information regarding poten-
tial side effects and ask them to report unexplained
muscle pain, tenderness, weakness, and dark-coloured
urine [20].
SPs were given clear instructions to not provide fur-
ther information unless requested by the pharmacy staff
member. If requested, the information subsequently pro-
vided is presented in Table 1. If pharmacists dispensed
medications without providing any counselling, the SPs
were instructed to pose specific questions to draw the
pharmacist’s attention to the counselling points that
need to be addressed (Table 1).
Documentation of the counselling process
To minimize recall bias, outside the pharmacy the coun-
selling process was documented on an assessment form
Table 1 Descriptions of scenarios
Scenario 1 Scenario 2
SP enters the pharmacy and asks: “May I have Ferose?” SP enters the pharmacy and asks: “May I have Amoxil?”
If asked, the SP told the pharmacy staff that she has not previously
taken the medicine, that it is for personal use, that she is 20 years old,
and that she has anaemia and sometimes takes antacid for stomach
upset. She also said that she has not received any information from
her doctor.
If asked, the SP told the pharmacy staff that she has not previously
taken the medicine, that it is for personal use, that she is 20 years old,
and that she has sore throat and is on birth control pills (Genera). She
also said that she has not received any information from her doctor.
If pharmacists provided no counselling, SPs asked the following: If pharmacists provided no counselling, SPs asked the following:
- May I take Ferose at any time? - May I take Amoxil at any time?
- May I take Ferose before or after a meal? - May I take Amoxil before or after a meal?
- I am using antacids occasionally. Is it OK to take both antacid and
Ferose at the same time?
- I am on Genera. Is it OK to take both Amoxil and Genera at the same
time?
Scenario 3 Scenario 4
SP enters the pharmacy and asks: “May I have Moxal?” SP enters the pharmacy and asks: “May I have Zocor?”
If asked, the SP told the pharmacy staff that she has not previously
taken the medicine, that it is for personal use, that she is 20 years old,
and that she has kidney failure. She also said that she has not received
any information from her doctor.
If asked, the SP told the pharmacy staff that the medicine is for her
mother, who is 70 years old, has not previously taken the medicine,
and has high cholesterol. She also said that she has not received any
information from her doctor.
If pharmacists provided no counselling, SPs asked the following: If pharmacists provided no counselling, SPs asked the following:
- May I take Moxal at any time? - Are there any side effects of this medicine that I should watch for?
- May I take Moxal before or after a meal?
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immediately after each visit. The form (available from
the corresponding author) was designed based on forms
from previously published work [17, 18]. The SPs were
familiarised with the standardised data collection form
before initiating the visits. They also practiced using the
form during the pilot study.
In all the scenarios, pharmacists were assessed on
whether they provided counselling, using the same cat-
egorisation as used by Tully et al. [18]. “No questioning”
was when the SP was not asked about previous use, use
of other medicines, allergies, and concerns about using
this medicine. “No information provision” was when no
verbal information was given about name of the medi-
cine, dose, how to take the medication, duration of use,
and possible adverse drug. “No counselling” was a lack
of both questioning and information provision. Further-
more, for each scenario pharmacists were expected to
provide any special directions or precautions.
Cross sectional survey of community pharmacists
The questionnaire in this study was a slightly modified
form of the questionnaire used in a previous study asses-
sing dispensing practices in Cyprus [17]. Two local phar-
macists checked the questionnaire for interpretation
issues and suitability to the Saudi setting.
The final questionnaire consisted of four sections (see
Additional file 1). The first section requested informa-
tion about the pharmacists’ demographics, average dis-
pensing time, and number of patients waiting. The
second section comprised 11 statements regarding infor-
mation that could be provided for customers during the
dispensing process. The pharmacist answered by provid-
ing an estimate of how often they offered this informa-
tion to patients. In the third section, the pharmacists’
views about their counselling were assessed. The final
section investigated any barriers to counselling.
As with the SPs study component, we stratified Riyadh
city by geographical areas and a convenient sample of
pharmacies from different areas was selected. Pharmacies
were visited by volunteer pharmacy students who asked
the pharmacists if they willing to participate in a study
about patient counselling in community pharmacies. Those
who agreed to participate were provided with a hard copy
of the questionnaire, which they completed while the stu-
dents were waiting in the pharmacy. The questionnaires
were not distributed to the same pharmacies that were vis-
ited by SPs. The questionnaires were distributed during dif-
ferent days of the week at different times of the day to
avoid targeting pharmacists only during busy hours or
days. The survey period was between April and May 2012.
Data analysis
Data from the SPs visits and survey were entered by a
research assistant and checked by one of the authors
(NA). The data were stored and analysed using Excel
2003. Continuous data are reported as mean and stand-
ard deviation (SD). Categorical data are expressed as fre-
quencies and percentages.
Ethical approval
This study involves observation of pharmacists’ behav-
iour and does not interfere with patient care. The study
was reviewed and approved by The institutional Review
Board at king Saud University. Information obtained is
recorded in such a manner that pharmacists involved
cannot be identified and results are reported in an an-
onymous way. This ensures that participating pharma-
cists are not at any risk of criminal or civil liability, and
it does not damage their employability or reputation.
Results
The simulated patients (SPs) method
One hundred and sixty one visits were conducted:
Scenario 1 = 49 (30 %), Scenario 2 = 50 (31 %), Scenario
3 = 20 (12 %), Scenario 4 = 42 (21 %). Two of the medi-
cations used in our scenarios are classified as POM.
Nonetheless, pharmacists dispensed Amoxil without ask-
ing for a prescription in all 50 SPs visits and dispensed
Zocor without a prescription in 31 out of 42 SPs visits
(74 %). This means out of the 161 visits a medicine was
dispensed in 150 visits.
The SPs had to wait on 65 out of 161 visits (40 %).
Time spent waiting for a visit was less than 1 min on 30
visits (18.6 %), 1–5 min on 30 visits (18.6 %), and more
than 6 min on 5 visits (3.1 %). On 67 occasions (41.6 %),
there were no other customers waiting. During other
visits, there were 1–2 customers waiting on 57 occasions
(35.4 %) and 3–5 customers waiting on 16 occasions
(9.9 %). These values do not total 161 where there is
missing data.
Data regarding the presence and content of counsel-
ling during dispensing are reported in Table 2. When
SPs requested medications, pharmacists asked questions
during 15 visits (10.0 %), provided information during 7
visits (4.6 %), and both asked questions and provided in-
formation, i.e. provided counselling, during 4 visits
(2.6 %).
When SPs started to be inquisitive and demanded in-
formation, this prompted pharmacists to ask questions
during 71 visits (47.3 %), provide information during 150
visits (100 %), and both ask questions and provide
information, i.e. provide counselling, during 65 visits
(43.3 %). The types of questions asked and information
given are reported in Table 2.
The majority of pharmacists did not inquire about pre-
vious use of requested medications, concomitant drugs
used, or any history of drug allergy. Information on dose
was the most common type of information provided
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during 146 visits (97.3 %). After the SPs started to be in-
quisitive and probed for information, only 10 % were
counselled on precautions.
Cross-sectional survey of community pharmacists
Four hundred pharmacists were approached and 350
agreed to participate in the questionnaire (87 % response
rate). Demographic information of the respondents is
provided in Table 3. The majority of respondents were
under 40 years of age (n = 321, 91.7 %). Only 15 respon-
dents (4.2 %) were of Saudi nationality and the
remaining were expatriates. Only 247 respondents pro-
vided their nationality and the majority were Egyptian
(n = 212, 60.5 %). The average experience as a commu-
nity pharmacist was 5 years (SD 4.5) inside Saudi and
3 years (SD 2.4) outside Saudi.
Table 4 illustrates the information that pharmacists
claimed to provide to clients. Respondents claim that
they frequently inform the patients about the dosing and
the instructions for taking drugs, and whether to take
medication with food or on an empty stomach. Accord-
ing to respondents, information on potential side effects,
drug interactions, and food interactions is provided less
frequently to patients.
The majority of pharmacists (86.6 %) believe that pa-
tients feel comfortable to consult their pharmacists
about their medication/medical condition (Table 5).
When asked about barriers to counselling (Table 6), over
half of respondents indicated that pharmacists are too
busy (59.6 %) and a similar proportion reported that
pharmacists do not have the patient medical history
(61.9 %).











Counselling before SP demanded information
Asked questions 15(10.0) 1 1 0 13
Provided information 7(4.6) 1 2 0 4
Counselling after demanding informationa
Asked questions 71(47.3) 18 11 14 28
Provided information 150(100.0) 48 50 20 32
Questions asked abouta
Who is medicine for 24(16.0) 2 4 3 15
Whether had taken this medicine before 12(8.0) 0 0 0 12
If other medicines currently being taken 14(9.3) 1 0 0 13
If allergic to any medicine 11(7.3) 0 0 0 11
If have any questions or concerns about this medicine 4(2.6) 1 0 0 3
Information provided about
Name of the medicine 10(6.6) 7 1 0 2
Dose 146(97.3) 46 50 19 31
How to take the medication (e.g. before or after meal) 109(72.7) 34 45 20 10
Duration of use 20(13.3) 3 5 3 9
Possible adverse drug reactions, warnings, and precautions 15(10.0) 3 2 2 8
aThe total number sometimes exceeds the number of visits as pharmacists may ask more than one question or provide more than one type of information during
a visit
bOut of the 161 visits a medicine was dispensed in only 150 visits













Doctor of pharmacy 72(21.5)
Others 3(0.85)
Years working as a community pharmacist
Inside Saudi Arabia 5 (SD 4.5, min <1 year, max 30 years)
Outside Saudi Arabia 3 (SD 2.4, min <1 year, max 16 years)
aThe total number does not always add up to 350 due to missing data
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Discussion
The present study evaluated the counselling practices of
community pharmacists in Riyadh, Saudi Arabia. Results
obtained from the visits using SPs were compared with
those obtained in the survey, revealing important dis-
crepancies regarding the frequency of information pro-
vided to customers. In the survey, the majority of the
respondents claimed that they always provide informa-
tion on dose, duration of use, and how to use the medi-
cation. Nevertheless, actual dispensing practices showed
that the majority of SPs were informed about such infor-
mation only when they started to be inquisitive and
probed for information. Others have reported similar in-
consistencies between self-reported behaviour of phar-
macists in interviews and their actual dispensing
practice measured using SPs [17]. It is possible that
pharmacists provide more socially desirable responses in
the questionnaires. Another possible explanation is that
the survey responses may refer to general counselling
practice, while the SPs component reflects counselling
practice on specific occasions when patients request a
medicine by name. Evidence suggests that the latter in-
volves less counselling [15, 21, 22].
Counselling rates reported in international literature
vary from 8 to 100 %, depending on the research
methods used [7]. The rate of counselling observed in
this study is very low (3 %). However, it improved to
43 % when SPs were inquisitive and requested more in-
formation. This improvement in observed counselling
rate is consistent with previous research reporting an as-
sociation between patient question-asking behaviour and
the provision of information [21, 22]. This improvement
in pharmacist-patient communication demonstrates the
importance of finding ways to encourage patients to ask
questions to community pharmacists.
When dispensing, the majority of pharmacists did not
inquire about previous use of the requested medications,
concomitant drugs, or history of drug allergy. In a study
involving simulated patients visiting community phar-
macies in Riyadh with symptoms of specific clinical ill-
nesses, antibiotics were dispensed without inquiring
about associated symptoms or history of drug allergy,
and only 23 % of pharmacists inquired about pregnancy
status [12]. Other studies also report that pharmacists’
assessment of symptoms and questioning concerning
medication history are inadequate [15–18, 21, 22]. One
explanation for this finding could be that our SPs were
asking for specific products. In the context of non-
prescription medicines, research suggests that product-
based requests result in less information being asked or
Table 4 Statements pharmacists identified as information they provide to patients about their prescription/medications (n = 350)a
Always (%) Usually (%) Often (%) Sometimes (%) Never (%)
The purpose of medication or diagnosis 126(36.0) 97(27.7) 64(18.3) 53(15.1) 4(1.1)
Dosing of the drugs 249(71.1) 72(20.5) 22(6.2) 4(1.1) 0(0)
Information on how to use the medication and its application 221(63.1) 81(23.1) 26(7.4) 8(2.3) 1(0.28)
Medication to be taken with food or on an empty stomach 213(60.8) 85(24.3) 25(7.1) 15(4.3) 3(0.85)
Duration of use 164(46.8) 73(20.8) 65(18.5) 31(8.8) 4(1.1)
Possible side effects 26(7.4) 33(9.4) 53(15.1) 76(21.7) 13(3.7)
Drug interactions 47(13.4) 56(21.1) 74(21.1) 139(39.7) 31(8.8)
Food interactions 55(15.7) 79(22.5) 81(23.1) 105(30.0) 23(6.5)
Importance of compliance 69(19.7) 68(22.5) 95(27.1) 84(24.0) 18(5.1)
Storage conditions 91(26.6) 79(22.5) 70(21.0) 78(22.2) 23(6.5)
Availability of generic medication 57(16.2) 84(24.0) 86(25.6) 93(27.6) 29(8.2)
aThe total number does not always add up to 350 because of missing data
Table 5 Statements given by pharmacists regarding their counselling practice (n = 350)a
Strongly agree (%) Agree (%) Unsure (%) Disagree (%) Strongly disagree (%)
Patients are comfortable in consulting me about their
medication/medical condition
106(30.3) 197(56.3) 33(9.4) 12(3.4) 1(0.28)
I use all opportunities to clarify patients’ understanding
of my counselling
118(33.7) 172(49.1) 48(13.7) 8(2.2) 1(0.28)
Patients understand the information I provide them 87(24.8) 172(49.1) 68(19.4) 13(3.7) 3(0.85)
I confirm and clarify the understanding of the patient 102(29.1) 172(49.1) 58(16.5) 6(1.7) 2(0.57)
I am satisfied with my counselling practice 130(37.1) 169(48.2) 34(10) 9(2.6) 4(1.1)
aThe total number does not always add up to 350 because of missing data
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information elicited by pharmacists than do symptom-
based [15, 21, 22]. Another plausible explanation is that
consumers might expect to make an OTC purchase
without being questioned [23]. However, in this study
two medications were POM. For one of these, Amoxil,
there was no assessment or request for a prescription.
Pharmacists’ assessment with the other, Zocor, was a lit-
tle better, but still unsatisfactory.
Information regarding dose was the most common
type of information provided (97 % of the SPs visits),
while a very small proportion of SPs were counselled on
precautions. This is consistent with findings in previous
research reporting that information on precautions,
side effects, interactions, contraindications, and stor-
age is less likely to be given by community pharma-
cists [7, 12, 13, 17, 18]. Interestingly, in our survey
approximately half of respondents reported that they
sometimes or never counselled on side effects and
drug interactions. Pharmacists may think that too
much information could deter patients from taking
their medications [24]. However, research suggests
that patients want specific information about side ef-
fects, duration of treatment, and the range of avail-
able treatment options [24].
Although two of the medications used in the scenarios
are POM, pharmacists requested the prescription on
only 11 out of 92 SPs visits. This confirms findings from
previous research that POMs, such as antibiotics, antihy-
pertensives, and antipsychotics could be obtained easily
without a medical prescription in Saudi Arabia [12, 13].
A Saudi study asked pharmacists (n = 60) for the reasons
they violated the law and dispensed POM without a pre-
scription [13]. The most common reasons given were
that pharmacists do not know the prescription status
(i.e. POM or OTC) of many medications, patients ask
for medications by name, and patients can only afford
the pharmacy visit. Some also reported that ‘if we did
not sell it somebody else will’ [13]. These results suggest
that the reasons for such malpractice are multifactorial,
and multiple approaches are required to correct it.
Implications for policy and research
The intensity of regulatory mechanisms has been pro-
posed as a factor influencing counselling practice
[25]. The Saudi Executives Roles for Institutional and
Pharmaceutical Products Law [9] provide no clear
regulation on what is expected of community phar-
macists during the dispensing of medications. There-
fore, the development of legislation or guidelines
setting out national standards that clearly stipulate
what is expected of community pharmacists during
the counselling process is needed. Such guidelines
should be supplemented by appropriate strategies for
dissemination and implementation.
There should be stringent enforcement of the national
regulations that require a valid prescription to dispense
a POM in community pharmacies. The Saudi Ministry
of Health have published a frequently updated version of
the Saudi OTC-Directory since 2000. Additionally, an
electronic list of medications licensed in Saudi Arabia,
including their prescription status, is available on the
Saudi FDA website [26]. However, this seems inadequate
and relevant agencies should develop strategies to ensure
efficient dissemination of information about the legal
status of medications to all community pharmacies.
Furthermore, the laws and regulations of the Saudi
healthcare system should be part of Saudi Commission
for Health Specialties licensing exam for pharmacists.
This is especially important given that most community
pharmacists in Saudi Arabia are expatriates.
Evidence for effective strategies to improve counselling
practices is limited. However, some interventions show
promising results, including continuous long-term post-
graduate education [27] and simulated patient visits to
assess the current practice followed by feedback [16, 21].
To promote longer-term changes in counselling prac-
tices, systematic action is required, coordinated between
relevant stakeholders and at different levels. Pharmacy
owners and pharmacists will need support and resources
to improve existing practice. These include management
systems, medicine information systems and databases,
and up-to-date basic and continuing education. At the
individual pharmacist level, competencies should be up-
dated to meet patient-centred practice requirements.
In this study, we only considered the provision of
counselling and not the quality of counselling. Therefore,
future studies that examine appropriateness and quality of
counselling practices are needed. Future research should
also investigate further the factors that hinder community
pharmacists from counselling patients. These factors may
Table 6 Statements given by pharmacists regarding barriers to counselling (n = 350)a
Strongly agree (%) Agree (%) Unsure (%) Disagree (%) Strongly disagree (%)
Pharmacists have limited drug information resources 41(11.7) 94(26.8) 48(13.7) 101(28.8) 64(18.3)
Pharmacists are too busy 68(19.4) 141(40.2) 51(14.5) 67(19.1) 18(5.1)
Pharmacists do not have the patient medical history 75(21.4) 142(40.5) 69(19.7) 40(11.4) 19(5.4)
Pharmacists lack confidence in their knowledge 27(7.7) 60(17.1) 50(14.2) 107(30.5) 105(30.0)
aThe total number does not always add up to 350 because of missing data
Alaqeel and Abanmy BMC Health Services Research  (2015) 15:557 Page 7 of 9
relate either to the community pharmacists them-
selves, for example competencies and willingness, or
to organizational factors, for example regulations and
reimbursements.
Limitations of the study
Some limitations of our study are outlined below. Our
results should be generalised with caution to the general
population due to our use of convenience sampling, as
this method can lead to the under-representation or
over-representation of particular groups within the sam-
ple. Further limitations include the use of students as
simulated patients, who may not have been as convin-
cing or as practiced as paid actors. Furthermore, the SPs
were all young females, and generalization of the find-
ings to other populations is not possible. Additionally,
SP visits were not audiotaped. Audiotaping can improve
the reliability of manually documented data and result in
more accurate assessments [28].
Some have expressed ethical concerns in relation to
the SPs method, as pharmacists do not give consent to
participate. However, others have argued that it can be a
robust method for assessing practice, and may be justi-
fied in the wider public interest [16].
The operational classification we used to assess coun-
selling was originally used within the context of pre-
scription medicines [18]. In such cases, a patient should
already have consulted with a medical practitioner and
pharmacists’ questioning serves the purpose of meeting
specific patient needs only. However, in the present
study two scenarios used OTC medications. For OTC
medications, pharmacists’ questioning serves a broader
purpose. It should not be limited to previous use, aller-
gies, use of other medicines, knowledge of indications,
or dosing instructions, but should include an assessment
of other aspects, namely nature of the symptoms, treat-
ment duration, and current conditions. The latter were
not investigated in this study.
The current study assessed the counselling process
only for situations where patients specifically request a
medication by name. Other situations, such as counsel-
ling for patients with prescriptions and for patients ap-
proaching pharmacists for treatment (i.e. explaining
their symptoms to pharmacists, who then provide them
with the medications), were not investigated. Therefore,
our findings cannot be extrapolated to such situations.
Conclusion
The present study highlights the current deficiencies in
appropriate dispensing practices and medication coun-
selling at community pharmacies in Saudi Arabia. Policy
makers, stakeholders, and researchers should collaborate
to design interventions to improve the current dispensing
practices at community pharmacies across the country.
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